NAYLET IGLESIAS: Open Payments
NPI 1477938355 · CORAL GABLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,213 in 58 payments from 16 companies in 2025. Trend: 2023 $13 · 2024 $132 · 2025 $1,213
Food & beverage: $1,129Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $219 |
| Madrigal Pharmaceuticals | 4 | $171 |
| Ardelyx, Inc. | 11 | $160 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $110 |
| PFIZER INC. | 5 | $76 |
| Intercept Pharmaceuticals, Inc. | 3 | $74 |
| Regeneron Healthcare Solutions, Inc. | 2 | $56 |
| ABBVIE INC. | 3 | $55 |
| Phathom Pharmaceuticals, Inc. | 3 | $55 |
| EVOKE PHARMA, INC. | 3 | $51 |
Products named: TREMFYA, REZDIFFRA, IBSRELA, DUPIXENT, ENTYVIO, VELSIPITY, OCALIVA, RINVOQ.
Industry payments across FL — which companies pay providers there.
